Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · MFS

MFS Total Return Fund C (MTRCX)

Ticker MTRCX · · Holdings as of Jun 30, 2026

Expense ratio
1.47%$147/yr per $10k
5-yr return
+5.5%annualized
1-yr return
+9.2%as of Dec 2025
Net assets
$7.4Ball share classes
Holdings
972

Bottom line

Is MTRCX a good fund? The bottom line

MTRCX is the C share class of MFS Total Return Fund, an actively managed large blend mutual fund from MFS.

Annual fees run 1.47% — about $147 a year on every $10,000 invested, more expensive than 82% of large blend funds we track.

It returned +9.2% over one year, +5.5% a year over five years, +6.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $7.4 billion in net assets and 972 holdings, its largest position is Charles Schwab Corp. (The) (2.5%) and the top 10 make up 18.5% of the portfolio.

What stands out

  • Broadly diversified (972 holdings)
  • No front-end sales load

What to watch

  • Expensive for its category (1.47%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What MTRCX invests in

The funds investment objective is to seek total return.

MFS (Massachusetts Financial Services Company, the funds investment adviser) invests the funds assets in equity securities and debt instruments. Equity securities include common stocks, depositary receipts, and other securities that represent an ownership interest (or right to acquire an ownership interest) in a company or other issuer. Debt instruments include corporate debt instruments, U.S. Government securities, securitized instruments (including mortgage-backed securities and other asset-backed securities), and other obligations to repay money borrowed. MFS generally invests approximately 60% of the funds assets in equity securities and approximately 40% of the fund's assets in debt instruments. These weightings do not reflect the fund's cash balance and can vary over time due to market movements and cash flows. Of the fund's investments in equity securities, MFS focuses on…

From the fund's prospectus (filed Jan 27, 2026).

MTRCX performance

Average annual total returns
1 yr5 yr10 yr
MTRCX+9.2%+5.5%+6.8%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full MTRCX performance history →

What MTRCX costs

On a $10,000 investment, MTRCX's 1.47% expense ratio costs about $147 a year. The prospectus estimates $1,554 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full MTRCX fee table →

MTRCX top 10 holdings

#Holding% of fund
1Charles Schwab Corp. (The)2.51%
2MFS Institutional Money Market Portfolio2.05%
3Microsoft Corp.2.01%
4Bank of America Corp.1.87%
5Pfizer, Inc.1.76%
6Medtronic plc1.73%
7Kenvue, Inc.1.66%
8Omnicom Group, Inc.1.65%
9Becton Dickinson & Co.1.64%
10Northern Trust Corp.1.61%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 18.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to MTRCX

More funds like MTRCX →

MTRCX FAQ

What is the expense ratio of MTRCX?
MTRCX's expense ratio is 1.47%, which works out to about $147 a year for every $10,000 invested. The prospectus estimates total costs of $1,554 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MTRCX a good investment?
It depends on your goals, but the data points to: broadly diversified (972 holdings); no front-end sales load; expensive for its category (1.47%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does MTRCX hold?
MTRCX's largest holdings are Charles Schwab Corp. (The) (2.5%), MFS Institutional Money Market Portfolio (2.1%), Microsoft Corp. (2.0%), Bank of America Corp. (1.9%), Pfizer, Inc. (1.8%). It holds 972 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MTRCX's 5-year return?
MTRCX returned +5.5% a year over the five years ending Dec 31, 2025, and +6.8% a year over ten years. Past performance does not guarantee future results.
Does MTRCX have a sales load?
No. MTRCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages MTRCX?
MTRCX is offered by MFS through Mfs Series Trust V.